SiS Weekly Scoop #53

🧬 OVO Labs Lands $4M to Extend Women’s Fertility Window‍

The London-based startup is developing hormone-regulating therapies designed to prolong reproductive health and delay menopause onset.
| 🔗 Read More

‍

🚀 Overture Life Secures $20.6M to Advance IVF Automation and Access‍

Backed by GV (Google Ventures), the company is scaling its robotic IVF platform to increase affordability and success rates globally.
| 🔗 Read More

“This new funding allows us to accelerate our expansion of IVF capabilities and demonstrates the value of operating within a CLIA-licensed laboratory environment, highlighting not only our technological leadership but also our commitment to the highest standards of clinical validation.”
— Hans Gangeskar, CEO, Overture Life

‍

⏪ HHS Reverses Controversial Cuts to Women’s Health Initiative‍

A major advocacy win: Following public outcry, HHS will restore funding to the Women’s Health Initiative, reaffirming federal support for gender-specific health research and programming.
| 🔗 Read More

‍

📱 Pacify & Seven Starling Partner on Comprehensive Maternal Health Benefits‍

This new partnership provides wraparound care, from lactation support to therapy and OB-GYN coordination, via employers and health plans.
| 🔗 Read More

‍

🧊 Coologics Raises $3M+ to Treat Vaginal Infections and Hot Flashes‍

The Ohio-based medtech startup is pioneering cooling-based tech to manage menopausal symptoms and treat recurrent infections.
| 🔗 Read More

“We are beyond excited about the investor commitment to Coologics. The overwhelming interest in our seed round validates the critical need for a more effective treatment for vaginal infections.”
— Dr. Kim Langdon, Founder & CEO, Coologics

‍

✨ Cacto Health Raises 3M DKK ($456,300 USD) to Tackle Breast Cancer Aftercare

Backed by leading investors, the Danish startup is bringing innovative home-monitoring to the fight against lymphedema, supporting 1 in 5 breast cancer survivors.
| 🔗 Read More

“It’s tough to stand in front of a group of investors and explain why fluid in the arm matters. Many see it as cosmetic – but it’s about pain, mobility, mental well-being, and quality of life. It should be common sense.”
— Ida Grønborg, CEO & Co-founder, Cacto Health

‍

✅ Ark Surgical Receives FDA Clearance for Fibroid Removal System‍

A new minimally invasive surgical tool designed to reduce the need for hysterectomy in fibroid treatment.
| 🔗 Read More

‍

Another major week for women’s health innovation, investment, and disruption. 👏